Showing 321 - 340 results of 103,918 for search '(( 50 ((mg decrease) OR (we decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  5. 325
  6. 326
  7. 327

    GFP activity is decreased in DES. by Céline Portal (3876436)

    Published 2017
    “…AB—PAS and serial immunohistochemical section of the left eye, which received PBS, and paired-right eye which received BAK show a decrease in the number of conjunctival goblet cells producing Muc5b (blue arrows) and non-Muc5b producing (white arrows) cells. …”
  8. 328
  9. 329
  10. 330
  11. 331

    Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

    Published 2020
    “…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I<sup>2</sup> = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”
  12. 332

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

    Published 2015
    “…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340